Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

FDA gives orphan status to Achillion's ACH-4471 for PNH

Nov. 8, 2017

Klotho Therapeutics announces series A financing to advance patent pending version of Klotho

Nov. 7, 2017

Ono Pharmaceutical divulges novel voltage-gated channel activators

Nov. 6, 2017

VS-505 effective and well tolerated hyperphosphatemia treatment for hemodialysis patients

Nov. 3, 2017

Cara Therapeutics doses first patient in study of CR-845

Oct. 26, 2017

FDA issues complete response letter for Xyosted

Oct. 23, 2017

Cara Therapeutics planning phase III pivotal program for CR-845

Oct. 17, 2017

Japan Tobacco enters licensing agreement for Rayaldee in Japan

Oct. 16, 2017

Vantia reports phase III topline data on fedovapagon for nocturia in men with BPH

Oct. 5, 2017

Soluble Nogo-B a potential treatment for diabetic glomerulopathy

Oct. 5, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...